The abortion pill is safe. But why should Trump let facts get in the way of his agenda? | Moira Donegan

The article discusses the recent review of mifepristone, the abortion pill, initiated by Robert F. Kennedy Jr.'s health department. The review cites a study from the conservative Ethics and Public Policy Center, which claims to have found concerns about the drug's safety. However, the article argues that this study is deeply flawed, with its methodology and data analysis heavily criticized by medical experts. In contrast, numerous reliable studies have repeatedly proven mifepristone to be safe and effective, with serious adverse health events occurring in fewer than 0.5% of users. The article suggests that this review may be driven by the Trump administration's agenda, rather than being based on factual evidence. It highlights the potential devastating impact this move could have on women's access to safe abortion services.